- Home
- MPAA vs ANVS Comparison
MPAA vs ANVS Comparison
Compare MPAA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- ANVS
- Stock Information
- Founded
- MPAA 1968
- ANVS 2008
- Country
- MPAA United States
- ANVS United States
- Employees
- MPAA N/A
- ANVS N/A
- Industry
- MPAA Auto Parts:O.E.M.
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- MPAA Consumer Discretionary
- ANVS Health Care
- Exchange
- MPAA Nasdaq
- ANVS Nasdaq
- Market Cap
- MPAA 138.3M
- ANVS 110.4M
- IPO Year
- MPAA 1994
- ANVS 2020
- Fundamental
- Price
- MPAA $6.20
- ANVS $7.95
- Analyst Decision
- MPAA
- ANVS Strong Buy
- Analyst Count
- MPAA 0
- ANVS 5
- Target Price
- MPAA N/A
- ANVS $30.60
- AVG Volume (30 Days)
- MPAA 93.4K
- ANVS 167.6K
- Earning Date
- MPAA 11-07-2024
- ANVS 11-06-2024
- Dividend Yield
- MPAA N/A
- ANVS N/A
- EPS Growth
- MPAA N/A
- ANVS N/A
- EPS
- MPAA N/A
- ANVS N/A
- Revenue
- MPAA $727,866,000.00
- ANVS N/A
- Revenue This Year
- MPAA $8.91
- ANVS N/A
- Revenue Next Year
- MPAA $6.99
- ANVS N/A
- P/E Ratio
- MPAA N/A
- ANVS N/A
- Revenue Growth
- MPAA 7.23
- ANVS N/A
- 52 Week Low
- MPAA $4.36
- ANVS $4.53
- 52 Week High
- MPAA $10.40
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- MPAA 45.84
- ANVS 41.64
- Support Level
- MPAA $6.41
- ANVS $7.84
- Resistance Level
- MPAA $6.40
- ANVS $8.13
- Average True Range (ATR)
- MPAA 0.33
- ANVS 0.48
- MACD
- MPAA -0.08
- ANVS -0.04
- Stochastic Oscillator
- MPAA 7.63
- ANVS 37.42
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.